Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | CASR | P41180 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23646254 | 1.00 | EPHX1 (0.52) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL23646220 | 1.00 | EPHX1 (0.52) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL31372304 | 0.98 | EPHX1 (0.55) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL23646260 | 0.98 | EPHX1 (0.55) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL31372135 | 0.98 | EPHX1 (0.55) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL23646217 | 0.98 | EPHX1 (0.55) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL23646196 | 0.96 | EPHX1 (0.49) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL31372261 | 0.96 | EPHX1 (0.49) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL23646185 | 0.94 | EPHX1 (0.48) | EPHX1RAB9ASLC6A3EPHX2GSK3B | |
| SCHEMBL23646222 | 0.94 | EPHX1 (0.48) | EPHX1RAB9ASLC6A3EPHX2GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12258324-B2 | Fatty acid analogues and methods of use | LIN BIOSCIENCE INC. (TW) | 2025-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12258324-B2 | Fatty acid analogues and methods of use | ELOVL1, FADS1, ALOX5 | EPHX1 1873/4885RAB9A 1045/4885SLC6A3 3024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.